Lesley Ogilvie is Director of the Secretariat at the Global Antimicrobial Resistance Research and Development Hub (Global AMR R&D Hub), a global partnership focused on addressing challenges and improving co-ordination and collaboration in AMR research and development using a One Health approach.
She has over 15 years of experience working in academia as a researcher and lecturer in Microbial Ecogenomics at the Universities of Brighton and East Anglia in the UK, and the Max Planck Institute for Molecular Genetics in Germany. Her research focus has been the role of the human gut virome/microbiome in health and disease and the discovery and characterisation of therapeutic phage. Lesley represents the Global AMR R&D Hub on a number of advisory groups, including for the World Health Organization and the European Commission, and is a member of the Applied Microbiology International One Health Advisory Group.